DDC
VIVO

DF Dent & Co’s Meridian Bioscience Inc VIVO Stock Holding History

DF Dent & Co’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-12,800
Closed -$226K – 169
2014
Q3 		$226K Hold
12,800
– – 0.01% 150
2014
Q2 		$264K Hold
12,800
– – 0.01% 145
2014
Q1 		$279K Sell
12,800
-1,000
-7% -$22.9K 0.01% 148
2013
Q4 		$366K Hold
13,800
– – 0.01% 176
2013
Q3 		$326K Hold
13,800
– – 0.01% 128
2013
Q2 		$297K Buy
+13,800
New +$298K 0.01% 132

Other funds holding VIVO

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DF Dent & Co's VIVO Position: Q4 2014 in Review

DF Dent & Co sold out of Meridian Bioscience Inc (VIVO) in Q4 2014, closing a stake of 12,800 shares — an estimated $226K sold.

DF Dent & Co first reported a position in VIVO in Q2 2013 and held it in 6 quarters. The position peaked at $366K in Q4 2013. 160 funds tracked by Wall St. Rank hold VIVO as of Q4 2014.

  • DF Dent & Co reported no remaining Meridian Bioscience Inc position as of Q4 2014 after selling out during the quarter.
  • DF Dent & Co sold 12,800 Meridian Bioscience Inc shares in Q4 2014, an estimated $226K.
  • DF Dent & Co first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 6 quarters.
  • DF Dent & Co's Meridian Bioscience Inc position peaked at $366K in Q4 2013.
  • 160 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2014.

Based on DF Dent & Co's 13F filing for Q4 2014, filed 12 Feb 2015.